866-997-4948(US-Canada Toll Free)

Global TB Diagnostic Market 2015-2019

Published By :

Technavio

Published Date : Jul 2015

Category :

Medical Equipments

No. of Pages : 82 Pages

About TB Diagnostics
TB is an infectious bacterial disease caused by Mycobacterium tuberculosis. It is communicable and can be transmitted from one person to another. TB is one of the worlds deadliest communicable diseases. In 2013, there were 9 million new TB cases and 1.5 million TB deaths, out of which 1.1 million among HIV-negative people and 0.4 million among HIV-positive people.

The symptoms of active TB of the lung include coughing, occasionally with sputum or blood, weakness, chest pains, weight loss, fever, and night sweats. Though the disease is preventive in developed countries, there is a shortage of efficient diagnosis tools and detection in developing countries.

Technavios analysts forecast the global TB diagnostic market to grow at a CAGR of 2.97% during the period 2014-2019.

Covered in this Report
The report covers the present scenario and the growth prospects of the global TB diagnostic market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales of TB diagnostic products in the market.

Technavio's report, Global TB Diagnostic Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the global TB diagnostics market landscape and its growth prospects over the coming years. The report includes a discussion of the key vendors operating in this market.

Key Geographies
Americas
APAC
EMEA

Key Vendors
Abbott
Alere
Becton, Dickinson
F. Hoffmann-La Roche

Other Prominent Vendors
Siemens
BioM
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Prevalence and Incidence Rate
08. Advances in Technology
08.1 Second-generation Nucleic Acid Detection
08.2 Next-generation Nucleic Acid Detection
09. TB Diagnostics Pipeline
10. Market Segmentation by Disease Stage
10.1 Global Latent TB Diagnostics Market
10.2 Global Active TB Diagnostics Market
10.3 Global Drug Susceptibility Tests Market
11. Geographical Segmentation
11.1 Global TB Diagnostics Market in APAC
11.1.1 India
11.2 Global TB Diagnostics Market in Americas
11.2.1 Brazil
11.3 Global TB Diagnostics Market in EMEA
11.3.1 South Africa
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and Their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and Their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2013
19.2.1 Abbott Diagnostics
19.2.2 Alere
19.2.3 BD
19.2.4 Roche Diagnostics
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Abbott Diagnostics
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Geographical Presence
20.1.4 SWOT Analysis
20.2 Alere
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Business Segmentation by Revenue 2013
20.2.4 Business Segmentation by Revenue 2012 and 2013
20.2.5 Geographical Segmentation by Revenue 2013
20.2.6 Business Strategy
20.2.7 Recent Developments
20.2.8 SWOT Analysis
20.3 BD
20.3.1 Key Facts
20.3.2 Business Description
20.3.3 Business Segmentation
20.3.4 Revenue Segmentation by Business
20.3.5 Segmental Revenue Comparison 2013 and 2012
20.3.6 Revenue Segmentation by Geography
20.3.7 Business Strategy
20.3.8 Key Developments
20.3.9 SWOT Analysis
20.4 Roche Diagnostics
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation by Revenue 2014
20.4.4 Business Segmentation by Revenue 2013 and 2014
20.4.5 Geographical Segmentation by Revenue 2014
20.4.6 Business Strategy
20.4.7 Recent Developments
20.4.8 SWOT Analysis
21. Other Reports in This Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global TB Diagnostics Market 2014-2019 ($ millions)
Exhibit 3: Incidence Rate per 100,000 Individuals 2013
Exhibit 4: High-burden Countries
Exhibit 5: Product Pipeline: TB Diagnostics
Exhibit 6: Segmentation of Global Active TB Diagnostics Market 2014
Exhibit 7: Segmentation of Global TB Diagnostics Market by Disease Stage 2014
Exhibit 8: Segmentation of Global TB Diagnostics Market by Geography 2014
Exhibit 9: India: Revenue Segmentation by Entity 2012
Exhibit 10: Public Sector: Segmentation of TB Diagnostics by Revenue 2012
Exhibit 11: Private Sector: Segmentation of TB Diagnostics by Revenue 2012
Exhibit 12: Brazil: Revenue Segmentation by Entity 2012
Exhibit 13: Brazil: Common TB Diagnostic Tests and Their Cost 2012
Exhibit 14: Brazil: Segmentation of TB Diagnostic Tests by Revenue 2012-2013
Exhibit 15: South Africa: Revenue Segmentation of TB Diagnostic Tests by Entity 2012-2013
Exhibit 16: Diagnostic Tests and Costs by Sectors
Exhibit 17: South Africa: Segmentation of TB by Revenue 2012-2013
Exhibit 18: South Africa: Volume of Tests in Public Sector 2012-2013
Exhibit 19: South Africa: Volume of Tests in Private Sector 2012-2013
Exhibit 20: Key Takeaways: Abbott Diagnostics
Exhibit 21: Key Takeaways: Alere
Exhibit 22: Key Takeaways: BD
Exhibit 23: Key Takeaways: Roche Diagnostics
Exhibit 24: Abbott Diagnostics: Geographical Presence
Exhibit 25: Alere: Business Segmentation by Revenue 2013
Exhibit 26: Alere: Business Segmentation by Revenue 2012 and 2013 ($ billions)
Exhibit 27: Alere: Geographical Segmentation by Revenue 2013
Exhibit 28: Product Categorization of BD
Exhibit 29: Revenue Segmentation of BD 2013
Exhibit 30: Revenue Comparison ($ millions)
Exhibit 31: Revenue Segmentation of BD by Geography 2013
Exhibit 32: Roche Diagnostics: Business Segmentation by Revenue 2014
Exhibit 33: Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 34: Roche Diagnostics: Geographical Segmentation by Revenue 2014

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *